OtherInflammation & Immunopharmacology
Inhibition of Endotoxin Response by E5564, a Novel TLR4- Directed Endotoxin Antagonist
Maureen Mullarkey, Jeffrey Rose, John Bristol, Tsutomu Kawata, William Christ, Akifumi Kimura, Seiichi Kobayashi, Melinda Przetak, Jesse Chow, Fabian Gusovsky and Daniel P Rossignol
Journal of Pharmacology and Experimental Therapeutics November 25, 2002, DOI: https://doi.org/10.1124/jpet.102.044487
Maureen Mullarkey
Jeffrey Rose
John Bristol
Tsutomu Kawata
William Christ
Akifumi Kimura
Seiichi Kobayashi
Melinda Przetak
Jesse Chow
Fabian Gusovsky
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherInflammation & Immunopharmacology
Inhibition of Endotoxin Response by E5564, a Novel TLR4- Directed Endotoxin Antagonist
Maureen Mullarkey, Jeffrey Rose, John Bristol, Tsutomu Kawata, William Christ, Akifumi Kimura, Seiichi Kobayashi, Melinda Przetak, Jesse Chow, Fabian Gusovsky and Daniel P Rossignol
Journal of Pharmacology and Experimental Therapeutics November 25, 2002, DOI: https://doi.org/10.1124/jpet.102.044487
OtherInflammation & Immunopharmacology
Inhibition of Endotoxin Response by E5564, a Novel TLR4- Directed Endotoxin Antagonist
Maureen Mullarkey, Jeffrey Rose, John Bristol, Tsutomu Kawata, William Christ, Akifumi Kimura, Seiichi Kobayashi, Melinda Przetak, Jesse Chow, Fabian Gusovsky and Daniel P Rossignol
Journal of Pharmacology and Experimental Therapeutics November 25, 2002, DOI: https://doi.org/10.1124/jpet.102.044487
Jump to section
Related Articles
Cited By...
Similar Articles
Advertisement